查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美生物反應器市場預測至 2030 年 - 區域分析 - 按規模、應用、技術和最終用戶
市場調查報告書
商品編碼
1533045

北美生物反應器市場預測至 2030 年 - 區域分析 - 按規模、應用、技術和最終用戶

North America Bioreactors Market Forecast to 2030 - Regional Analysis - by Scale, Application, Technology, and End User
出版日期: | 出版商: The Insight Partners | 英文 76 Pages | 訂單完成後即時交付

價格

2022年北美生物反應器市值為15.756億美元，預計到2030年將達到26.690億美元；預計2022年至2030年複合年成長率為6.8%。

擴大採用一次性生物反應器推動北美生物反應器市場

許多製造商正在開發一次性生物反應器 (SUB)，因為它們堅固耐用，並提供生物製藥商業製造所需的高性能。薄膜技術、攪拌機制、生物反應器設計和感測器系統等優勢有助於提高一次性反應器從實驗室到生產規模的採用。一次性生物反應器提供下一代細胞和基因療法以及連續生物加工。細胞培養過程的進步已經產生了更高的滴度和細胞密度，這促進了 SUB 的採用。

一次性生物反應器可降低污染風險並縮短生產週轉時間。在過去幾年中，一次性生物反應器在現代生物製藥製程中的使用有所增加，因為它們具有增強靈活性、減少投資和限制營運成本的獨特能力。此外，許多公司還開發了一次性生物反應器來生產各種治療藥物。例如，2021 年 3 月，Thermo Fischer Scientific 推出了 3,000 L 和 5,000 L HyPerforma DynaDrive 一次性生物反應器。

縮短驗證時間是一次性生物反應器的基本優勢之一。上游生物加工擴大採用一次性生物反應器正在推動市場成長。例如，Sartorius AG 提供各種一次性生物反應器。該公司提供適用於 10-15 mL 微型生物反應器規模的 ambr 15 和適用於 50-2000L 規模的 Biostat STR。人們越來越接受一次性生物反應器用於生產治療藥物，這正在推動生物反應器市場的發展。

北美生物反應器市場概況

美國是生物反應器的最大市場——美國的一些市場參與者為製藥和生物技術公司的各種應用製造生物反應器。新生物反應器的推出、地理擴張以及市場參與者的合作夥伴關係推動了市場的成長。 2023 年 4 月，BioMADE 宣布了五個新項目，重點是透過推進生物反應器技術來解決美國生物工業製造的研究和採用差距。這些項目的資金承諾為 1050 萬美元，涵蓋工程、硬體開發和可擴展性，以解決加速強勁經濟的障礙。這些項目專注於創新，並將在施密特期貨的支持下推進生物反應器的設計和開發。 2023 年 4 月，Cytiva 推出了 X 平台生物反應器，以一次性產品簡化上游生物加工作業。最初，生物反應器的可用尺寸為 50 公升和 200 公升。然而，X-Platform 生物反應器配備了 Figurate 自動化解決方案軟體，可透過人體工學改進、生產能力和簡化供應鏈操作來提高製程效率。

北美生物反應器市場收入及 2030 年預測（百萬美元）

北美生物反應器市場細分

北美生物反應器市場根據規模、應用、技術、最終用戶和國家進行細分。根據規模，北美生物反應器市場分為實驗室規模生產、中試規模生產和大規模生產。 2022年，中試規模生產領域佔最大的市場佔有率。

在應用方面，北美生物反應器市場分為微生物應用、細胞培養應用等。 2022年，細胞培養應用領域佔據最大的市場佔有率。

依技術分類，北美生物反應器市場分為補料生物反應器和灌流生物反應器。補料式生物反應器領域在 2022 年將佔據更大的市場佔有率。

根據最終用戶，北美生物反應器市場分為生物製藥製造商、研發組織和合約製造組織。 2022 年，研發組織部門佔據最大的市場佔有率。

根據國家/地區，北美生物反應器市場分為美國、加拿大和墨西哥。 2022年，美國在北美生物反應器市場佔有率中佔據主導地位。

PBS Biotech Inc、通用電氣公司、默克、Thermo Fisher Scientific Inc、Sartorius AG、頗爾公司、Solaris Biotechnology SRL 和 Applikon Biotechnology BV 是北美生物反應器市場的一些領先參與者。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美生物反應器市場 - 主要產業動態

  • 生物反應器市場 - 主要產業動態
  • 市場促進因素
    • 擴大採用一次性生物反應器
    • 醫藥及生技產業快速成長
  • 市場限制
    • 嚴格的規範架構
  • 市場機會
    • 對個人化醫療的需求不斷成長
  • 未來趨勢
    • 生物反應器的技術進步
  • 促進因素和限制的影響：

第 5 章：生物反應器市場 - 北美市場分析

  • 概述
  • 生物反應器市場收入，2020 - 2030

第 6 章：北美生物反應器市場分析 - 規模

  • 概述
  • 2022 年和 2030 年生物反應器市場收入佔有率（按規模）
  • 實驗室規模生產
    • 概述
    • 實驗室規模生產市場、收入與 2030 年預測
  • 中試規模生產
    • 概述
    • 中試規模生產市場、收入與 2030 年預測
  • 全面製作
    • 概述
    • 全面生產市場、收入和 2030 年預測

第 7 章：北美生物反應器市場分析 - 應用

  • 概述
  • 2022 年和 2030 年按應用分類的生物反應器市場收入佔有率 (%)
  • 微生物應用
    • 概述
    • 微生物應用市場、收入與 2030 年預測
  • 細胞培養應用
    • 概述
    • 細胞培養應用市場、收入及2030年預測
  • 其他
    • 概述
    • 其他市場、收入和 2030 年預測

第 8 章：北美生物反應器市場分析 - 技術

  • 概述
  • 2022 年和 2030 年按技術分類的生物反應器市場收入佔有率 (%)
  • 補料分批生物反應器
    • 概述
    • 補料分批生物反應器市場、收入和 2030 年預測
  • 灌註生物反應器
    • 概述
    • 灌註生物反應器市場、收入和 2030 年預測

第 9 章：北美生物反應器市場分析 - 最終用戶

  • 概述
  • 2022 年和 2030 年按最終用戶分類的生物反應器市場收入佔有率 (%)
  • 生物製藥製造商
    • 概述
    • 生物製藥製造商市場、收入和 2030 年預測
  • 研究與開發組織
    • 概述
    • 研究與開發組織市場、收入和 2030 年預測
  • 合約製造組織
    • 概述
    • 合約製造組織市場、收入和 2030 年預測

第 10 章：北美生物反應器市場 - 按國家分析

  • 北美洲

第 11 章：生物反應器市場-產業格局

  • 概述
  • 生物反應器市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • PBS Biotech Inc
  • General Electric Co
  • Merck KGaA
  • Thermo Fisher Scientific Inc
  • Sartorius AG
  • Pall Corp
  • Solaris Biotechnology SRL
  • Applikon Biotechnology BV

第 13 章：附錄

Product Code: TIPRE00011475

The North America bioreactors market was valued at US$ 1,575.60 million in 2022 and is expected to reach US$ 2,669.00 million by 2030; it is estimated to grow at a CAGR of 6.8% from 2022 to 2030 .

Increasing Adoption of Single-Use Bioreactors Fuels North America Bioreactors Market

Various manufacturers are developing single-use bioreactors (SUBs) as they are robust and provide the high performance required for commercial manufacturing of biopharmaceuticals. Advantages such as film technologies, stirring mechanisms, bioreactor designs, and sensor systems have contributed toward increasing the adoption of disposable reactors from the lab to the production scale. The single-use bioreactors provide next-generation cell and gene therapies and continuous bioprocessing. The advancements in cell-culture processes have developed higher titers and cell densities, which have facilitated the adoption of SUBs.

Single-use bioreactors reduce the risks of contamination and decrease production turnaround times. In the last few years, the use of single-use bioreactors has increased in modern biopharmaceutical processes owing to their unique ability to enhance flexibility, reduce investment, and limit operational costs. Also, many companies have developed single-use bioreactors for producing a wide range of therapeutics. For instance, in March 2021, Thermo Fischer Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors.

The reduction in validation time has been one of the essential benefits of single-use bioreactors. The rising adoption of single-use bioreactors for upstream bioprocessing is driving the market growth. For instance, Sartorius AG offers a wide range of single-use bioreactors. The company provides ambr 15 for a 10-15 mL micro bioreactor scale and Biostat STR for 50-2000L. The increasing acceptance of single-use bioreactors for the production of therapeutics is driving the market for bioreactors.

North America Bioreactors Market Overview

The US is the largest market for bioreactors-several market players in the US manufacture bioreactors for various applications in pharmaceutical and biotechnology companies. Launch of new bioreactors, geographical expansion, and partnerships by market players drive the growth of the market. In April 2023, BioMADE announced five new projects focused on addressing the research and adoption gaps in bioindustrial manufacturing in the US by advancing bioreactor technology. With a funding commitment of US$ 10.5 million, these projects would span engineering, hardware development, and scalability to address the barriers to accelerate a robust economy. These projects focus on innovation and will advance the design and development of bioreactors, supported by Schmidt Futures. In April 2023, Cytiva launched X-platform bioreactors to simplify upstream bioprocessing operations with single-use products. Initially, available sizes of bioreactors were 50 and 200L. However, the X-Platform bioreactors are equipped with Figurate automation solution software and can increase process efficiency through ergonomic improvements, production capacity, and simplified supply chain operations.

North America Bioreactors Market Revenue and Forecast to 2030 (US$ Million)

North America Bioreactors Market Segmentation

The North America bioreactors market is segmented based on scale, application, technology, end user, and country. Based on scale, the North America bioreactors market is segmented into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held the largest market share in 2022.

In terms of application, the North America bioreactors market is segmented into microbial application, cell culture application, and others. The cell culture application segment held the largest market share in 2022.

By technology, the North America bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held a larger market share in 2022.

Based on end user, the North America bioreactors market is categorized into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held the largest market share in 2022.

Based on country, the North America bioreactors market is segmented into the US, Canada, and Mexico. The US dominated the North America bioreactors market share in 2022.

PBS Biotech Inc, General Electric Co, Merck KGaA, Thermo Fisher Scientific Inc, Sartorius AG, Pall Corp, Solaris Biotechnology SRL, and Applikon Biotechnology BV are some of the leading players operating in the North America bioreactors market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Bioreactors Market - Key Industry Dynamics

  • 4.1 Bioreactors Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Adoption of Single-Use Bioreactors
    • 4.2.2 Rapid Growth of Pharmaceutical and Biotechnology Industry
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Framework
  • 4.4 Market Opportunities
    • 4.4.1 Rising Demand for Personalized Medicine
  • 4.5 Future Trends
    • 4.5.1 Technological Advancements in Bioreactors
  • 4.6 Impact of Drivers and Restraints:

5. Bioreactors Market - North America Market Analysis

  • 5.1 Overview
  • 5.2 Bioreactors Market Revenue (US$ Million), 2020 - 2030

6. North America Bioreactors Market Analysis - Scale

  • 6.1 Overview
  • 6.2 Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
  • 6.3 Lab-Scale Production
    • 6.3.1 Overview
    • 6.3.2 Lab-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Pilot-Scale Production
    • 6.4.1 Overview
    • 6.4.2 Pilot-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Full-Scale Productions
    • 6.5.1 Overview
    • 6.5.2 Full-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)

7. North America Bioreactors Market Analysis - Application

  • 7.1 Overview
  • 7.2 Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Microbial Application
    • 7.3.1 Overview
    • 7.3.2 Microbial Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Cell Culture Application
    • 7.4.1 Overview
    • 7.4.2 Cell Culture Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

8. North America Bioreactors Market Analysis - Technology

  • 8.1 Overview
  • 8.2 Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Fed-Batch Bioreactors
    • 8.3.1 Overview
    • 8.3.2 Fed-Batch Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Perfusion Bioreactors
    • 8.4.1 Overview
    • 8.4.2 Perfusion Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)

9. North America Bioreactors Market Analysis - End User

  • 9.1 Overview
  • 9.2 Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Biopharma Manufacturers
    • 9.3.1 Overview
    • 9.3.2 Biopharma Manufacturers Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Research and Development Organizations
    • 9.4.1 Overview
    • 9.4.2 Research and Development Organizations Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Contract Manufacturing Organization
    • 9.5.1 Overview
    • 9.5.2 Contract Manufacturing Organization Market, Revenue and Forecast to 2030 (US$ Million)

10. North America Bioreactors Market - by Country Analysis

  • 10.1 North America: Bioreactors Market
    • 10.1.1 North America Bioreactors Market Revenue and Forecasts and Analysis - By Country
      • 10.1.1.1 United States
      • 10.1.1.2 Overview
      • 10.1.1.3 US: Bioreactors Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 United States Bioreactors Market Breakdown by Scale
        • 10.1.1.3.2 United States Bioreactors Market Breakdown by Application
        • 10.1.1.3.3 United States Bioreactors Market Breakdown by Technology
        • 10.1.1.3.4 United States Bioreactors Market Breakdown by End User
      • 10.1.1.4 Canada
      • 10.1.1.5 Overview
      • 10.1.1.6 Canada: Bioreactors Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Canada Bioreactors Market Breakdown by Scale
        • 10.1.1.6.2 Canada Bioreactors Market Breakdown by Application
        • 10.1.1.6.3 Canada Bioreactors Market Breakdown by Technology
        • 10.1.1.6.4 Canada Bioreactors Market Breakdown by End User
      • 10.1.1.7 Mexico
      • 10.1.1.8 Overview
      • 10.1.1.9 Mexico: Bioreactors Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.9.1 Mexico Bioreactors Market Breakdown by Scale
        • 10.1.1.9.2 Mexico Bioreactors Market Breakdown by Application
        • 10.1.1.9.3 Mexico Bioreactors Market Breakdown by Technology
        • 10.1.1.9.4 Mexico Bioreactors Market Breakdown by End User

11. Bioreactors Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Bioreactors Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 PBS Biotech Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 General Electric Co
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Merck KGaA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Thermo Fisher Scientific Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Sartorius AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Pall Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Solaris Biotechnology SRL
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Applikon Biotechnology BV
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Bioreactors Market Segmentation
  • Table 2. United States Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Scale
  • Table 3. United States Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Application
  • Table 4. United States Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Technology
  • Table 5. United States Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 6. Canada Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Scale
  • Table 7. Canada Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Application
  • Table 8. Canada Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Technology
  • Table 9. Canada Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 10. Mexico Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Scale
  • Table 11. Mexico Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Application
  • Table 12. Mexico Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Technology
  • Table 13. Mexico Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 14. Recent Inorganic Growth Strategies in the Bioreactors Market
  • Table 15. Recent Organic Growth Strategies in the Bioreactors Market
  • Table 16. Glossary of Terms, Bioreactors Market

List Of Figures

  • Figure 1. Bioreactors Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Bioreactors Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
  • Figure 5. Lab-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Pilot-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Full-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 9. Microbial Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Cell Culture Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 13. Fed-Batch Bioreactors Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Perfusion Bioreactors Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 16. Biopharma Manufacturers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 17. Research and Development Organizations Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Contract Manufacturing Organization Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. North America: Bioreactors Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 20. North America Bioreactors Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 21. United States Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 22. Canada Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 23. Mexico Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 24. Growth Strategies in the Bioreactors Market